American Association for Cancer Research (AACR)

Coronavirus Information and Resources: Learn how the COVID-19 pandemic has created special challenges for cancer patients, survivors, and their families.

Learn More

Cancer Today

Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.

Cancer Types

Approximately 74,000 people in the United States like Billy Foster are diagnosed with kidney cancer each year. Learn about this type of cancer including the treatment options.

Learn More

From the Blog

Lung cancer screening reduced deaths but is underutilized.

Read in the AACR Blog

Innovators in Discovery

Learn about cancer researchers and physician-scientists like former AACR President and Fellow of the AACR Academy Michael A. Caligiuri, MD, who are leading progress against cancer.

Learn More

Ways to Give

Plan Your Legacy: Learn how you can have a lasting impact on scientific discovery and innovation in the treatment and prevention of cancer for generations to come.

Learn More

For Researchers

AACR Annual Meeting

Notice of Termination and Rescheduling
The AACR Board of Directors has made the difficult decision, after careful consideration of currently available information related to the novel coronavirus outbreak, to terminate the AACR Annual Meeting 2020, originally scheduled for April 24-29 in San Diego, California. A rescheduled meeting is being planned for later this year.

Learn More

Videos

Driving Progress Against Cancer

The American Association for Cancer Research (AACR) and our more than 44,000 members worldwide are advancing a scientifically bold agenda against the collection of devastating diseases we call cancer.

Keeping Breast Cancer at Bay with Immunotherapy

Eva was devastated to learn her triple-negative breast cancer had spread to her lungs and sternum, but immunotherapy has allowed her and her husband to enjoy retirement together.

Charles L. Sawyers, MD: Fellow of the AACR Academy

A physician-scientist and leader in the development of targeted therapies for cancer, Dr. Sawyers investigates the signaling pathways that drive the growth and drug resistance of cancer cells.